Overview Fundamentals API Earnings EOD API Sample Code Pricing

Hemostemix Inc (HMTXF PINK) stock market data APIs

$0.04 0(0%) as of July 12, 2024
Price chart is built with Anychart

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Hemostemix Inc Financial Data Overview

0.04
0.04
-
0.04
0.04
0.0291-0.1362
2 875 K
87 122 K
0
-0.004
0.374
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'HMTXF',
Type: 'Common Stock',
Name: 'Hemostemix Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00BNK7P48',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Hemostemix Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -1 559 628
  • Earnings Per Share -0.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Hemostemix Inc Earnings via APIs

  • Latest Release 2024-05-30
  • EPS/Forecast NaN

Get Hemostemix Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com